Skip to Main Content

Paper Details

Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.
Proc Natl Acad Sci U S A
19
2022
BER genes, CRPC, CRPC cells, DDR genes, DNA damage repair (DDR) genes, EZH2, EZH2 gain-of-function mutations, P300, cancer, castration-resistant prostate cancer, non-Hodgkin lymphomas, pioneer factor FOXA1, polycomb, solid tumors, wild-type EZH2
Author NameAffiliation
Chen-Hao ChenHarvard T.H. Chan School of Public Health
Chen-Hao ChenDana-Farber Cancer Institute
Chen-Hao ChenCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Changmeng CaiCenter for Personalized Cancer Therapy, University of Massachusetts
Shuai GaoCenter for Personalized Cancer Therapy, University of Massachusetts
Zhao ZhangUniversity of Texas Health Science Center at San Antonio
Wei LiCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Wei LiDana-Farber Cancer Institute
Fei TengCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Fei TengDana-Farber Cancer Institute, Harvard Medical School
James E BradnerBrigham and Women's Hospital, Harvard Medical School
James E BradnerHarvard Medical School
Kornelia PolyakCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Kornelia PolyakDana-Farber Cancer Institute, Harvard Medical School
Kornelia PolyakCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Kornelia PolyakDana-Farber Cancer Institute, Harvard Medical School
Philip W KantoffCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Philip W KantoffDana-Farber Cancer Institute, Harvard Medical School
Philip W KantoffCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Philip W KantoffDana-Farber Cancer Institute, Harvard Medical School
Steven P BalkBeth Israel Deaconess Medical Center
Xiaole Shirley LiuCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Xiaole Shirley LiuDana-Farber Cancer Institute
Xiaole Shirley LiuHarvard T.H. Chan School of Public Health
Myles BrownCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Myles BrownDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 26

Datasets